159 studies found for: Open Studies | "Influenza, Human"
Treatment of Severe Influenza A Infection
Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children Aged 6~35 Months
Screening Volunteers for Influenza Challenge Studies
|4||Not yet recruiting||
Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines
|5||Not yet recruiting||
Prevalence, Strain Circulation and Disease Burden Study of Seasonal Influenza A and B in Panama, Selected Countries of Central America and the Caribbean From the Year 2010 to 2015
Tropical Influenza Control Strategies for the Elderly
Evaluating the Use of Oseltamivir for the Treatment of Influenza in Adults
|8||Not yet recruiting||
Childhood Influenza Immunisation in General Practice Invitation Trial
A Pilot Study of Influenza Viruses Isolated From Immunocompromised Children and Adolescents
|10||Not yet recruiting||
Assessment of the Clinical Performance of the ARROW-FLU System
|11||Not yet recruiting||
Immunogenicity of Twice-annual Influenza Vaccination in Older Adults in Hong Kong
A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.
Safety and Effectiveness of a Seasonal Live Attenuated Influenza Vaccine in a Human Challenge Model of Infection With Wild-type (wt) Influenza A/California/2009 (H1N1)-Like Virus
A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 6 Months Through 59 Months of Age.
|15||Not yet recruiting||
Evaluation of the Cepheid Genexpert Flu/RSV Assay for Management of Influenza in the Emergency Department
Banlangen Granules Anti-seasonal Influenza Study
Study of a Single Dose or Two Doses of a Quadrivalent Influenza Vaccine in Subjects Aged 6 Months or Older in India
A Clinical Trial of KT07 Capsule in the U.S.A
Analysis of Bone Marrow and Blood B Cell Immune Responses to Influenza Vaccination
Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects
† Study has passed its completion date and status has not been verified in more than two years.